A detailed, data-driven guide to help you make the right investment for your practice.
A detailed breakdown across every metric that matters to your practice.
Adjust the patient volume to see the real cost difference over time.
Drag the slider to model your expected patient volume (series of 4 treatments each)
80% of dry eye is meibomian gland dysfunction. IPL alone treats the surface — RF reaches the glands.
Meibomian glands sit at 2mm depth. Only Envision's Forma-I reaches them.
"You can stop putting hair down the drain, but if you don't roto-rooter the clog, it still won't work right."
IPL stops inflammation (the hair). RF unclogs the glands (the drain). You need both.
IPL = optical energy at 300nm depth. Targets inflammation, reds, browns in the epidermis. Not regenerative — zero studies show IPL stimulates collagen.
RF = electrical energy at 2mm depth. Proven neo-collagenic across dermatology, physiotherapy. Hundreds of studies confirm tissue regeneration.
Lumecca's left-switch focused IPL concentrates most energy between 400-600nm — the exact wavelengths that clear neovascular blood vessels, inflammation, rosacea, and telangiectasia. Standard IPL (including OptiLight) uses a wave-style effect capturing only 10-15% at these critical wavelengths.
Lumecca-I vs Other IPLs — The Critical Differences
Learn the basic science of IPL and what makes Lumecca unique from every other IPL on the market.
Click any question for a detailed, data-backed answer.
50+ OptiLight accounts have chosen Envision since its US soft launch.
Showing 15 of 39+ verified accounts. Additional accounts available upon request.
"Very effective, wide range coverage and front loaded. Easy to use and much simpler — no need for filter changes. Not painful for patients unlike OptiLight."
Dr. Jennifer Tsai, OD
Line of Sight, NYC — Former OptiLight user, switched to Envision
All data in this guide is sourced from published specifications and clinical market research.
View Source Research Document